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Copyright © 2009 JCBN Summary Retinoic acid (RA) has been effective for improving wrinkles. However, it has also
been reported that RA induces skin irritation. In this study, we explored new botanical
compounds that show RA-like activity, but do not induce inflammation in vitro. Keratinocytes
were maintained in a confluent condition and induced differentiation. Under this condition
keratinocytes were treated with many botanical extracts and their morphological change were
observed and compared with RA-treated. We found that silybin, which is a major flavonolignan
from Silybum Marianum seeds, induced RA-like morphological change and prevented differ-
entiation. We showed that silybin, like RA, reduced the expression of keratinocyte terminal
differentiation markers and stimulated the expression of basement membrane component
proteins. In contrast, silybin, unlike RA, did not stimulate the secretion of IL-1α, which is a
skin irritation mediator. These results suggest that silybin has RA-like activity on keratino-
cytes and has the potential to improve winkle without inducing skin irritation.
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Introduction
Signs of cutaneous aging like wrinkling and sagging
develop earlier in sun-exposed skin. This is known as photo-
aging [1]. It is characterized by a decrease in the amount
and degeneration of collagen, dermal elastosis, and glyco-
saminoglycan deposition [2, 3], and damages to the connec-
tive tissues of the skin, which is composed primarily of
collagen fiber bundles, elastic fibers and basement mem-
branes [4]. Treatment for the changes responsible for fine
and deep wrinkles in photoaged skin is therefore an impor-
tant cosmetic issue.
The topical application of retinoids such as all-trans-
retinoic acid (RA) and retinol induce repair of UV-damaged
skin in vivo, leading to the effacement of wrinkles [5, 6].
Large double-blind, vehicle-controlled studies have provided
incontrovertible evidence that the topical administration of
RA improves wrinkles considerably [7]. At the molecular
level, retinoids exert their effects through two families of
nuclear receptors, namely the retinoid A receptor (RAR)
and retinoid X receptor (RXR), and change the expression
of various genes, including the enhancement of collagen
synthesis [8], keratinocyte proliferation [9] and inhibition of
keratinocyte differentiation [10]. In human skin, RARγ and
RXRα, whose heterodimeric partner is RXRα and RXRγ,
are the predominant species. RA promotes the production
activities of extra cellular matrix (ECM) and reduces the
collagenase level by the inhibition of activator protein-1
(AP-1) transcriptional activities [11,  12]. Recent studies
have shown that RA exerts its effects through heparin-
binding epidermal growth factor (HB-EGF) and epidermal
growth factor receptor (EGFR) [13, 14]. Many studies have
reported that these changes influence skin, causing epidermal
hyperproliferation, compaction of the stratum corneum, and
the improvement of wrinkling [15]. However, it has also
been reported that RA cause skin irritation, including
burning, itching, and erythema [16, 17].Silybin Inhibits Keratinocytes Differentiation
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In this study, we investigated a new functional compound
with RA-like activity, but which does not induce skin irrita-
tion. To find this compound, we searched for compounds
that have the same inhibitory effect on confluent-induced
keratinocytes differentiation that retinoic acid induces,
without inducing interleuikin1-α, a skin irritation marker.
We identified silybin as a new active component. Silybin is
a plant-derived flavonoid from Silybum marianum and it is a
one of the oldest known and most widely used traditional
European medicine, and has mainly been used for liver
disorders [18]. We investigated the effects of silybin
treatment on keratinocytes, and demonstrated that silybin
modulated the expression of keratinocyte differentiation-
associated markers like RA, and stimulated the expression of
basement membrane component proteins such as laminin-5
and laminin-5 receptor, integrin β4, effectively as RA.
Unlike retinoic acid, however, silybin does not stimulate
IL-1α production. These results suggest that silybin may
have a functional component that improves wrinkling
without inducing skin irritation.
Materials and Methods
Materials and cell culture
RA, silybin were purchased from Sigma-Aldrich Co.
(St. Louis, MO). Various botanical extracts, used in
screening study, were originally extracted from each plant in
our laboratory or purchased from each supplying company.
Our extracts were obtained by using Accelerated Solvent
Extractor (Dionex, Sunnyvale, CA), after mixing 40 ml
95% ethanol and each 1 g dry plants, purchased from each
supplying company. Obtained extracts were concentrated
under reduced pressure. Silymarin, which is an extract from
Silybum Marianum. seeds,  and involve silybin as major
consists, were purchased from Indena S.P.A. (Milano, Italy).
RA, silybin and each various botanical extracts were
dissolved in DMSO, and redissolved in KGM (Cambrex
Bioscience, East Rutherford, NJ). Normal human epidermal
keratinocytes isolated from adult breast skin were purchased
from Cambrex Bioscience.
Confluent-induced keratinocyte differentiation assay
The keratinocytes were seeded at 5 × 104 cells per well in
6-well plates and cultured in KGM allowing the cells to
attach overnight. For the succeeding culture days, these
cells were cultured in KGM with various compounds and
botanical extracts by changing the growth medium every
two days. When the cells were grown to confluence six days
later, morphological changes were observed by using a
microscope.
Western blotting
For western blotting of cellular proteins, keratinocytes
were lysed using protein extraction reagent (Pierce Bio-
technology, Rockford, IL). The lysates were centrifuged
at 12,000 g for 15 min and the supernatants were collected.
For western blotting of laminin-γ2, cellular media were
collected and concentrated by centrifugal filter device
(Millipore, Billerica, MA). The protein concentration was
determined by BCA (bicinchoninic acid) assay according to
the supplier’s protocol. Equal amounts of protein (20 μg)
were separated by 10% sodium dodecyl sulphate (SDS)-
polyacrylamide gel electrophoresis and transferred to PVDF
(polyvinylidene difluoride) membranes. The membranes
were subsequently blocked with 5% skim milk in TBS⁄ T
(20 mM Tris-HCl at pH 7.6, 137 mM NaCl, 0.1% Tween 20)
and incubated with primary antibody for 2 h. After several
washes, the HRP-conjugated secondary antibody was added
(final dilution 1:10000) for 2 h at room temperature. The
signals were detected using the enhanced ECL Plus Western
Blotting Detection System (GE Healthcare, Piscataway, NJ).
Interleukin-1α production assay
For detection of Interleukin-1α (IL-1α), keratinocytes
were seeded at 3 × 105 cells per well in a 10 cm dish and
cultured in KGM, allowing the cells to attach overnight.
After these cells were incubated in KGM with RA or silybin
for 4 days, the cellular media were collected and examined
the amount of IL-1α examined by using a human IL-1α
ELISA kit (Pierce).
RXRα, RARα protein interaction
To investigate whether silybin could interact and trans-
locate both the RXRα and RARα, we used the PathHunter
profiling system from DiscoveRx Corporation (Fremont,
CA) [19]. The protein interaction assay is based on detection
of protein-protein interactions between an activated, full
length NHR protein and a nuclear fusion protein containing
Steroid Receptor Coactivator Peptide (SCRP) domains with
one or more canonical LXXLL interaction motifs. The NHR
is tagged with the ProLinkTM component of our EFC assay
system, and the SRCP domain is fused to the enzyme
acceptor component (EA) expressed in the nucleus. When
bound by ligands, the NHR will recruit the SRCP domain,
and complementation will occur, generating an active β-Gal
enzyme and production of a chemiluminescent signal. The
PathHunter NHRPro Cell lines which express each RXRα
and RARα protein, were expanded from freezer stocks in
flasks according to standard procedures and maintained.
For profiling, the cells were seeded into 384 well micro-
plates at a density of 10000 cells per well in a total volume
of 50 μl and were allowed to adhere overnight. An inter-
mediate dilution of compound stocks was generated such
that 5.5 μl of 10X compound could be added to each well
with a final DMSO concentration of 1% of total volume. For
profiling the compound in the agonist mode, the cells wereS. Kitajima and K. Yamaguchi
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incubated in the presence of compound at 37°C for 5 h.
After appropriate compound incubation, an assay signal was
generated through a single addition of PathHunter Detection
reagent cocktail (DiscoveRx) for the agonist assays followed
by one hour incubation at room temperature. Microplates
were read following signal generation with a PerkinElmer
(Waltham, MA) ViewLuxTM instrument for chemilumines-
cent signal detection.
Results
Screening of compounds with retinoid-like activities in
keratinocytes
First, we explored the screening methods that could easily
detect retinoic acid (RA)-like activities in keratinocytes. We
found that keratinocytes treated with RA showed morpho-
logical changes in the confluent condition. In confluent
conditions, DMSO-treated control keratinocytes showed a
flatter cell shape and observed like differentiated cells
(Fig. 1Ab). These keratinocytes did not maintain prolifera-
tion activities (data not shown). However, keratinocytes
incubated with RA did not show the flattened changes that
were observed like proliferating keratinocytes (Fig. 1Aa, c).
To look them like profiling cells, we also examined whether
RA-treated keratinocytes maintain proliferation activity by
measuring the growth rate after reseeding the confluence
cells, and detected proliferation of these cells (data not
shown). These data indicate RA-treatment maintained
proliferation activity, and inhibited confluent-induced
morphological changes like differentiated keratinocytes.
Next we explored new RA-like compounds by observing the
morphological changes of the keratinocytes in the confluent
and differentiated conditions. Using this confluenced-
induced differentiation assay, we examined 300 compounds
and botanical extracts. We found that treatment with
silymarin and silybin, which is a major biologically active
component of silymarin complex, isolated from seeds of
the milk thistle (Silybum marianum L. Gaertn.) induced
morphological change and show phenotype like differentia-
tion cells like RA (Fig. 1Ad). Treatment with silybin also
preserved the proliferation of keratinocyte (data not shown).
Silybin is a flavonolignan (Fig. 1B), and the major bio-
logically active constituent of silymarin. Silymarin, which
has antioxidant activities, is one of the oldest known herbal
extracts and is a widely used traditional European medicine
for liver disorders.
Modulation of expression on keratinocyte differentiation-
associated markers by silybin
It has been shown that keratinocytes change their gene
expression by differentiation stage, and that also RA acts
predominantly on the latter process to inhibit the expression
Fig. 1. Phase-contrast image of keratinocytes treated with RA or silybin on confluent-induced differentiation (A). (a), not confluent
proliferative keratinocyte. Keratinocytes were incubated in KGM with DMSO (b), RA 1 μM (c), silybin 10 μM (d) for six days
and inhibitory effects of RA and silybin on morphological and cell-differentiation were observed. Structure of silybin (B).
Western blot analysis keratinocytes differentiation-assoiated markers (C).Silybin Inhibits Keratinocytes Differentiation
Vol. 45, No. 2, 2009
181
of differentiation-associated markers [20–24]. Therefore,
we examined the effect of silybin on the expression of
keratinocyte differentiation-associated markers. Under
confluent conditions, silybin treatment reduced the expres-
sion of taransglutaminase-1 (TGase1), keratin 1, and loricrin
dose-dependently and also did not change the expression of
keratin 5 like RA (Fig. 1C). As determined these result,
silybin shows RA-like activities in the keratinocytes con-
fluent condition, reduced the expression of differentiation-
associated markers, and inhibited differentiation.
Effect of silybin on the secretion of interleukin 1α
We examined the cytotoxity of silybin by LDH (lactate
dehydrogenase)-cytotoxic test, and compared with RA.
LDH-cytotoxity assay reveals that both SB (Sigma) 10 μM-
and RA 1 μM-treatment did not affect cytotoxicity (data not
shown). However it has been reported that RA stimulate the
secretion of IL-1α [ 25,  26], which is well known as an
inflammatory mediator in acute inflammation of the skin
[27] and which induces skin irritation. Therefore, we next
examined the effect of silybin on the secretion of IL-1α and
compared it with RA. RA increased the secretion of IL-1α
from keratinocytes, but silybin did not (Fig. 2). The concen-
tration of IL-1α secreted from RA 1 μM-treated cells was
five-hold higher than SB 10 μM-treated cells, as these
show the same effect on the inhibition of confluent-induced
morphological change. It was suggested that silybin had
the capacity to induce lower inflammation and irritation to
the skin than RA and retinoids.
Effect of silybin on the interaction and translocation of
RXRα, RARα protein
It was shown that RA interacts and translocates RXR and
RAR protein to nuclear and activates transcription of their
receptor’s targets. To examine this effect of silybin, we used
an enzyme fragment complementation technology system
provided by the DiscoveRx Corporation and compared it
with activities of RA. The concentration of silybin used 3 or
10 μM, which was used in both experiments on confluence-
induced keratinocyte differentiation (Fig. 1A) and on the
secretion of IL-1α (Fig. 2). As shown in Fig. 3, RA signifi-
cantly interacts and translocates both RXRα and RARα, and
exhibited agonist activities to these receptors. In contrast,
silybin did not exhibit these activities at 10 μM.
Fig. 2. Effect of silybin and retinoic acid on the secretion of
interleukin 1α. The effect of silybin and retinoic acid-
treatment on the secretion of interleukin 1α, which is
well known as an inflammatory mediator in acute
inflammation of the skin, were examined. The secretion
of interleukin-1α in KC culture media incubated with
RA 0.25 and 1 μM, but not silybin 10 μM, were
increased. Each value represents the mean ± SD (bar)
for triplicate assays. *p<0.05.
Fig. 3. Modulatoin of RARα and RXRα agonist activity after RA and silybin treatment. RA exhibited strong agonist activity with
RARα and RXRα, no activity was observed with silybin. Each value represents the mean ± SD (bar) for triplicate assays.
**p<0.001 verses DMSO.S. Kitajima and K. Yamaguchi
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Effect of silybin on the production of basement membrane
proteins such as laminin 5 and integrin β4
It has been reported that the increase of laminin 5 produc-
tion in epidermal cells enhanced the repair of damaged
basement membrane of skin and this may be an effective
approach to prevent the wrinkling and sagging that occurs
[28]. Our previous study has shown that RA increased the
production of laminin 5 and integrin α6 and β4, heterodimers
which are receptors of laminin 5, in keratinocytes and
inhibited cells damaged by UV irradiation. Therefore, we
investigated the effects of silybin-treatment on the produc-
tion of laminin 5 and integrin β4. Treatment with silybin
enhanced the production of laminin 5 and integrin β4 in
keratinocytes (Fig. 4). These data suggest that both RA and
silybin stimulated the production of basement membrane
proteins.
Discussion
In this study, we investigated a new functional compound
which showed activities like RA without its side effects,
such as not inducing IL-1 in keratinocytes. RA and retinoids
have been considered among the most beneficial compounds
for the improvement of wrinkles [29]. Many studies have
presented functional evidence of these effects by amassing
clinical data on skin [30]. These reports show that RA
stimulates cell proliferation in the basal and spinous layers
of the skin, leading to thickening. In addition, RA further
modulates ECM proteins synthesis and inhibits collagenase
production through retinoid receptors and AP-1 activation
in vivo [10]. Recently, some studies have suggested that RA
induced HB-EGF production and EGER signaling [13, 14].
However in vitro, meaning in monolayer keratinocytes, the
effect of RA has not been clarified and a useful method for
screening RA-like compounds has not existed. Therefore,
we established an easy screening method to observe
morphological changes of differentiated cells under the
confluent conditions. Using this method, we investigated
new compounds like RA. As a result, we determined that
silybin shows cell shape changes similar to RA under a
differentiated condition (Fig. 1A). Silybin treatment does
not cause flattened cell shape changes, and show cell shapes
like proliferative cells. Furthermore we examined the effect
of silybin on the expression of differentiation-associated
markers, and showed that silybin reduced the expression
level of the terminal differentiation markers trans-
glutaminase1, loricrin and keratin1 (Fig. 1C). These results
demonstrate that both silybin and RA inhibit confluent-
induced keratinocyte differentiation.
Silybin has traditionally been used to treat liver disorders
[18]. It has also been known that silybin exerts its effect by
it strong anti-oxidant activities [31]. A number of studies
also have shown that silybin suppress UV-induced photo-
carcinogenesis and cell damage by its antioxidant effects
[32, 33]. Because we used a confluent-induce differentiation
condition, it can be assumed that the effect of silybin in
this study was independent of silybin’s strong anti-oxidant
activities. Furthermore silybin did not bind and activate
retinoid receptors such as RARα and RXRα (Fig. 3). These
data may indicate that silybin shows RA-like cellular
morphological changes through other mechanism and signal
cascade. Our studies also revealed that RA stimulated IL-1α
production in keratinocytes, but silybin did not (Fig. 2). This
data may support that silybin modulate through the different
pathway with RA.
However, our results showed that both RA and silybin
stimulated the expression basement membrane proteins,
laminin-5 and integrin β4 (Fig. 4). In addition our finding,
it has been observed that silybin reduces MMPs (matrix
metalloproteinase) activation in tumors [34] and also
inhibits UVB- and EGF-induced signaling involving AP-1
and nuclear factor-κB (NF-κB) in JB6 cells [35]. It has
been known that RA also influenced these molecules [6].
Although there are various difference in cell types and
stimulating inducers that used between these studies and our
study, these results indicate that silybin and RA show both
different and similar effect, and their control mechanism
may be partly different. It might be suggested that silybin
directly targets downstream of RA signaling pathway or
modulate through non-classical routes of RA, such as activa-
tion of HB-EGF and unknown mechanism. Although further
studies will be necessary to understand the mechanism
that silybin affect in this confluent-induced condition, these
studies in silybin may be useful tool for particular under-
standing of RA signaling cascade.
We demonstrated that RA stimulated IL-1α production in
keratinocytes, but silybin did not (Fig. 2). This difference
results in IL-1α induction has led us to conclude that silybin
is a more useful and safe compound in keratinocytes and
skin, because silybin shows RA-like activities without
Fig. 4. Effect of SB treatment on laminin-5, laminin receptor,
integrin  β4. Keratinocytes were treated with RA or
silybin and induced differentiation. After six days cell
and medium were collected, and used for western blot.Silybin Inhibits Keratinocytes Differentiation
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inducing inflammatory mediators. It seems that silybin does
not appear to have a negative RA effect in keratinocytes and
skin. Recently it has been shown that silymarin, is composed
primarily of silybin, has the ability to protect mice from
UVB-induced immunosuppression and that this protective
effect is mediated, at least in part, through IL-12 [36].
This activity which regulates the secretion of cytokines may
contribute to the inhibition of IL-1α secretion directly.
We also found that both silybin and RA induced laminin-
5 and the laminin receptor integrin β4 (Fig. 4). Laminin-5 is
a major basement membrane component. Several studies
indicate that basement membrane components are affected
by photoaging, but that these effects are modulated by RA.
In this study, we revealed that laminin-5 protein synthesis
was induced by silybin and RA treatment. Another laminin-
5 receptor integrin β4, was also induced by silybin and RA
treatment. These effects on the production of these two
proteins may explain that both silybin and RA induced the
similar cell phenotype changes, although RA shows these
activities through retinoid receptors while silybin does not.
A method that measures the production of these proteins
might be useful for the screening of RA-like compounds.
In addition, silybin might modulate basement membrane
components, and might affect photoaging, inducing an im-
provement in wrinkling.
In summary, the results presented in this report demon-
strate that silybin inhibited confluent-induced keratinocyte
differentiation and modulates the production of basement
membrane components like RA. However, unlike RA,
silybin did not induce inflammatory changes such as the
stimulation of interleukin-1α in keratinocytes. These results
strongly suggest that silybin might be a potential agent for
the prevention and safe treatment of skin aging and
wrinkling.
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